Focus on Cancer
ReachMD
According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind these advances: medications that hone in on specific tumor targets, more accurate screening and diagnostic technologies, and pioneering surgical methods that provide new hope for patients suffering from these devastating diseases.
Location:
United States
Networks:
ReachMD
Description:
According to the American Cancer Society, yearly deaths from cancer are decreasing— marking the first period of decline in nearly 70 years. ReachMD takes a closer look at the driving forces behind these advances: medications that hone in on specific tumor targets, more accurate screening and diagnostic technologies, and pioneering surgical methods that provide new hope for patients suffering from these devastating diseases.
Language:
English
Website:
http://www.reachmd.com/
Episodes
Tackling the Challenges of Care Coordination in NSCLC
1/15/2019
Host: Jennifer Caudle, DO
Guest: Christine Bestvina, MD
Family physician Dr. Jennifer Caudle and oncologist Dr. Christine Bestvina come together to take on the many questions surrounding care coordination in non-small cell lung cancer. Addressing a variety of topics like the various physicians involved and the challenges often encountered, Dr. Bestvina reveals the key strategies of seamless multidisciplinary teams to help you improve patient outcomes. Closing the Gaps in NSCLC is...
Duration:00:08:59
An Overwhelming Outcome After a NSCLC Patient's Change in Care
1/15/2019
Host: Matt Birnholz, MD
Guest: Christine Bestvina, MD
Dr. Christine Bestvina, Assistant Professor of Medical Oncology at the University of Chicago, retells the case of one non-small cell lung cancer patient whose need for a change in treatment course halfway through proved to be rewarding for both her and her patient. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health...
Duration:00:02:59
Latest Guidelines Bring Change for NSCLC Care
1/15/2019
Host: Matt Birnholz, MD
Guest: Christine Bestvina, MD
Highlighting the new guidelines brought forth by the National Comprehensive Cancer Network is Dr. Christine Bestvina, Assistant Professor of Medical Oncology from the University of Chicago. With this new and important information in mind, she explores how these modifications will impact the way we approach caring for our patients with non-small cell lung cancer. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this...
Duration:00:02:59
A Practical Perspective on Aggressive Disease Management in NSCLC
12/10/2018
Host: Matt Birnholz, MD
Guest: Everett E. Vokes, MD
Flipping the term “aggressive” on its head is Dr. Everett Vokes from the University of Chicago. Dr. Vokes unveils the term “intensive therapy” to describe his approach to aggressive NSCLC management and provides us with his rationale behind implementing this approach into practice. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is...
Duration:00:01:29
Clinical Pearls for Challenging Cases of Advanced NSCLC
12/10/2018
Host: Matt Birnholz, MD
Guest: Everett E. Vokes, MD
With no one patient being the same, there’s a lot to consider when developing a treatment plan for advanced non-small cell lung cancer, and complex cases, such as elderly patients, can bring considerable uncertainty. Dr. Everett Vokes dives into the strategies he uses to guide his decisions when he’s faced with a challenging case. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is...
Duration:00:03:29
Facing False Positives in CT-Based NSCLC Screenings
12/10/2018
Host: Matt Birnholz, MD
Guest: Everett E. Vokes, MD
To address some of the difficulties surrounding CT-based NSCLC screenings, Dr. Everett Vokes provides guidance to thwart false positives. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Duration:00:02:29
Evolving Insights into the Pathophysiology of NSCLC
12/10/2018
Guest: Everett E. Vokes, MD
Over the years, we’ve seen insights and advances emerge in the field of NSCLC, leading to better physician understanding and patient management. But at the heart of all breakthroughs and innovations lies the foundation of disease pathophysiology. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Duration:00:02:29
Revealing the Key Statistics of NSCLC
12/10/2018
Guest: Everett E. Vokes, MD
Dr. Everett Vokes, Professor at the University of Chicago, brings to light the reality of one of the deadliest diseases in the United States and the glaring repercussions encountered. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Duration:00:01:29
The Expanding Value of Biomarkers in NSCLC Treatment
12/1/2018
Host: Shira Johnson, MD
Guest: Ross Camidge, MD, PhD
The treatment landscape for non-small cell lung cancer is continuing to expand, and playing a major role in clinical decision-making are biomarkers. Dr. Ross Camidge reveals the importance of these molecular signatures with Dr. Shira Johnson and how he applies them in practice. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is...
Duration:00:11:59
Doctor-Patient Relationship Remedies in NSCLC
11/30/2018
Host: Shira Johnson, MD
Guest: Ross Camidge, MD, PhD
Building a strong physician-patient relationship is in many ways a complex process. But since it’s the foundation to exceptional care in NSCLC, this trust and confidence could influence your patient’s decision to take or skip the next dose. Dr. Ross Camidge from the University of Colorado discusses the strategies she implements in her practice to optimize partnerships with patients. Closing the Gaps in NSCLC is sponsored by Lilly....
Duration:00:12:59
A Memorable Lesson Learned from a Patient with NSCLC
11/30/2018
Host: Matt Birnholz, MD
Guest: Ross Camidge, MD, PhD
After repeated chemotherapy sessions, many patients feel the repercussions and pain. But beyond the pain is the loss of quality of life. Dr. Ross Camidge, Director of Thoracic Oncology at the University of Colorado Cancer Center, navigates us through one unforgettable case of a patient with NSCLC, which holds an unexpected lesson for all physicians Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified...
Duration:00:03:29
NSCLC: An Aggressive Approach for Personalized Therapy
11/30/2018
Guest: Ross Camidge, MD, PhD
Dr. Ross Camidge from the University of Colorado discusses the concepts to consider and his own personal rationales behind implementing aggressive disease management for patients with NSCLC. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Duration:00:02:59
The Value of Multidisciplinary Teams in NSCLC Care Plans
11/9/2018
Guest: Edward S. Kim, MD
At the very least, any successful non-small cell lung cancer (NSCLC) care team needs to include a medical oncologist, pulmonologist, pathologist, radiologist, and even a molecular pathologist. Reviewing the value of each of these roles in tackling NSCLC is Dr. Edward Kim, Chair of Solid Tumor Oncology and Investigational Therapeutics at Levine Cancer Institute. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is...
Duration:00:02:59
An NSCLC Expert’s Take on Aggressive Disease Management
11/9/2018
Guest: Edward S. Kim, MD
What’s the best course of action for those patients with non-small cell lung cancer (NSCLC) that’s rapidly growing? Join Dr. Edward Kim, Chair of Solid Tumor Oncology and Investigational Therapeutics at Levine Cancer Institute, as he reviews some of the methods that aim to achieve the best response rate in these patients. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This...
Duration:00:02:59
Perspectives on How KEYNOTE-189 Is Changing NSCLC Care Paradigms
11/9/2018
Guest: Edward S. Kim, MD
For those non-small cell lung cancer (NSCLC) patients without driver mutations or PD-L expressions, the new care paradigm brought on by KEYNOTE-189 has shown to improve these patients’ progression-free survival rates. Here to break down this clinical trial’s unprecedented findings is Dr. Edward Kim, Chair of Solid Tumor Oncology and Investigational Therapeutics at Levine Cancer Institute. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this...
Duration:00:03:30
Keys to Accurate Diagnostic Staging for NSCLC
11/9/2018
Guest: Edward S. Kim, MD
Obtaining a tissue biopsy has always been the standard for reaching both early and late-stage non-small cell lung cancer (NSCLC) diagnoses, but that’s no longer the case for all stages. See for yourself how the paradigm has changed with Dr. Edward Kim, Chair of Solid Tumor Oncology and Investigational Therapeutics at Levine Cancer Institute. Closing the Gaps in NSCLC is sponsored by Lilly. Content for this non-certified educational series is produced and controlled...
Duration:00:02:59
Unraveling Disease Progression Predictors of mCRC
11/8/2018
Guest: Benjamin A. Weinberg, MD
Dr. Benjamin Weinberg, assistant professor at Georgetown University, examines the determinants of disease progression of metastatic colorectal cancer and how these can lead to better approaches to tailored care and personalized management of your patients. Conversations on Colorectal Cancer is sponsored by Lilly. Content for this non-certified educational series is produced and controlled by ReachMD. This series is intended for health care professionals only.
Duration:00:01:59
NCCN Guidelines on mCRC in an Era of Tumor Sidedness
11/7/2018
Guest: Benjamin A. Weinberg, MD
Keeping up with rapid advancements in mCRC, the NCCN updated their guidelines to encompass the perplexity of tumor sidedness. Dr. Benjamin Weinberg, Assistant Professor at Georgetown University, interprets the distinctions between right versus left-sided tumor sites and how these developments could impact your treatment selection for patients. Conversations on Colorectal Cancer is sponsored by Lilly. Content for this non-certified educational series is...
Duration:00:01:59
Expanding NCCN Guidelines for mCRC Care
11/7/2018
Guest: Benjamin A. Weinberg, MD
The NCCN guidelines are the foundation of clinical practice, supporting the decisions of all in the oncology community. For this reason, advancements in the therapeutic landscape of metastatic colorectal cancer have led to necessary adaptations of the guidelines. Reflecting on these influential modifications is Dr. Benjamin Weinberg, Assistant Professor at Georgetown University. Conversations on Colorectal Cancer is sponsored by Lilly. Content for this...
Duration:00:03:29
Right-Left Divide: Prognostic Importance of Tumor Sidedness
11/7/2018
Guest: Benjamin A. Weinberg, MD
Over the years, tumor sidedness has become an area of immense interest for the oncology community. And while they have shown inferior outcomes for patients with the primary site on the right side versus the left, questions still remain as to why. Dr. Benjamin Weinberg, an Assistant Professor at Georgetown University, details why sidedness may be a prominent prognostic indicator. Conversations on Colorectal Cancer is sponsored by Lilly. Content for this...
Duration:00:01:59